DrugPatentWatch Database Preview
Drugs in Development Information for TAK-448
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for TAK-448?
TAK-448 is an investigational drug.
There have been 320 clinical trials for TAK-448.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2018.
The most common disease conditions in clinical trials are Diabetes Mellitus, Hypertension, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Takeda, Millennium Pharmaceuticals, Inc., and National Cancer Institute (NCI).
There are two US patents protecting this investigational drug and forty-two international patents.
Summary for TAK-448
| US Patents | 2 |
| International Patents | 42 |
| US Patent Applications | 4 |
| WIPO Patent Applications | 1 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2018-01-01) |
| Vendors | 2 |
Recent Clinical Trials for TAK-448
| Title | Sponsor | Phase |
|---|---|---|
| A Pharmacokinetic and Safety Study of TAK-925 in Participants With Idiopathic Hypersomnia | Millennium Pharmaceuticals, Inc. | Phase 1 |
| A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection | Takeda | Phase 3 |
| A Study of TAK-994 in Participants With Narcolepsy Type 1 | Takeda | Phase 1 |
Clinical Trial Summary for TAK-448
Top disease conditions for TAK-448
Top clinical trial sponsors for TAK-448
US Patents for TAK-448
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| TAK-448 | Start Trial | Metastin derivatives and use thereof | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| TAK-448 | Start Trial | Metastin derivatives and use thereof | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for TAK-448
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| TAK-448 | Argentina | 058584 | 2025-12-22 | Start Trial |
| TAK-448 | Argentina | 106545 | 2025-12-22 | Start Trial |
| TAK-448 | Austria | 521632 | 2025-12-22 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
